I would invest $10,000 into these ASX 200 shares today

These are the ASX 200 shares I would happily invest my hard-earned money into today.

| More on:
Hand holding Australian dollar (AUD) bills, symbolising ex dividend day. Passive income.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're lucky enough to have $10,000 to invest in the share market this week, then I would seriously consider putting the funds into the three ASX 200 shares listed below.

That's because I believe the risk/reward on offer with all three shares is very attractive, and outsized returns could be on the cards over the next 12 months.

Here's why I would invest $10,000 into these ASX 200 shares:

Lovisa Holdings Ltd (ASX: LOV)

This fashion jewellery retailer's shares have fallen heavily from their 52-week high amid concerns over the impact of interest rate rises on consumer spending. While Lovisa's sales will inevitably take some form of hit, the company is likely to be less impacted than most retailers due to its low price points and younger target demographic. In addition, with Lovisa continuing to expand its store footprint globally, I agree with consensus estimates that its earnings can grow approximately 30% in FY 2024. As a result, I believe this ASX 200 share is good value at 24 times estimated FY 2024 earnings.

Qantas Airways Limited (ASX: QAN)

It certainly has been a tough few months for Qantas, its board, and its share price. But if you look beneath the controversy, I believe you will find an extremely compelling investment opportunity. The Flying Kangaroo's market capitalisation remains less than it was before the pandemic. That's despite the company's structural cost-out program and significantly improved earnings capacity. Another potential positive waiting in the wings is the return of its dividend. I suspect the ASX 200 share could bring it back this year or next.

ResMed Inc (ASX: RMD)

A final ASX 200 share that I would invest $10,000 into is ResMed. The emergence of wonder drugs like Ozempic as a weight loss treatment recently sent investors into a spin and this sleep treatment company's shares crashing deep into the red. While Ozempic and other glucagon-like peptide 1 (GLP-1) agonists could reduce ResMed's total addressable market in the future, I believe the sheer size of the market means it will have barely any noticeable impact on the company's growth. After all, ResMed estimates that ~1 billion people suffer from sleep apnoea globally. There's definitely room for both treatment options if you ask me. And ResMed doesn't come with any worrying side effects.

Motley Fool contributor James Mickleboro has positions in Lovisa and ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Lovisa and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Lovisa. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

People of different ethnicities in a room taking a big selfie, symbolising diversification.
Opinions

Want diversification? Get it instantly with these ASX 200 shares

Some businesses offer a lot more diversification than others.

Read more »

A happy man and woman on a computer at Christmas, indicating a positive trend for retail shares.
Opinions

2 ASX 200 shares I'd want to receive as a present today

Merry Christmas! Are there any stocks under your tree?

Read more »

Young boy in business suit punches the air as he finishes ahead of another boy in a box car race.
Opinions

Why I think these 2 ASX 300 stocks will beat the market in 2025

I’m very optimistic about a few ASX growth shares.

Read more »

A businessman compares the growth trajectory of property versus shares.
Opinions

What's the outlook for shares vs. property in 2025?

The experts have put out their new year predictions...

Read more »

Cheerful boyfriend showing mobile phone to girlfriend in dining room. They are spending leisure time together at home and planning their financial future.
Opinions

My ASX share portfolio is up 30% this year! Here's my plan for 2025

The best investing plans shouldn't need too many updates.

Read more »

Man in an office celebrates at he crosses a finish line before his colleagues.
Opinions

These stocks made my share portfolio a market-beater in 2024

Beating the market is the least important takeaway from this year.

Read more »

A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
Opinions

2 underappreciated ASX 200 shares to buy now

Investors may be undervaluing these ASX 200 shares heading into 2025, according to this expert.

Read more »

A man wearing a shirt, tie and hard hat sits in an office and marks dates in his diary.
Resources Shares

Is the BHP share price a buy? Here's my view

Is it time to dig into this beaten-up miner?

Read more »